Cynosure Management, LLC Repligen Corp Transaction History
Cynosure Management, LLC
- $552 Million
- Q1 2024
A detailed history of Cynosure Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Cynosure Management, LLC holds 1,652 shares of RGEN stock, worth $197,893. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,652Holding current value
$197,893% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
521Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$931 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$611 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$427 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$211 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$175 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.65B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....